Document is current
Any future updates will be listed below
-
Authors
Xiao, Wei
Chen, Yi-long
Du, Long-yi
Wu, Jiqiu
Wang, Zhang
Mao, Bing
Wen, Fu-qiang
Gibson, Peter Gerard
McDonald, Vanessa M.
Yu, Haopeng
Fu, Juan-juan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No.82100046)
National Natural Science Foundation of China (No.81870014)
Sichuan Science and Technology Program of China (2023NSFSC1460)
Sichuan Science and Technology Program of China (2020YFS0145)
- License Information
-
More Information
Article History
Received: 8 November 2023
Accepted: 3 April 2024
First Online: 20 April 2024
Declarations
:
: The EndAECOPD study was approved by the Clinical Trial and Biomedical Ethics Committee of West China Hospital of Sichuan University (No.2018 − 298). The study protocol was registered at the Chinese Clinical Trial Registry (ChiCTR1800019063) on 24 October 2018. This study was conducted in strict accordance with the Declaration of Helsinki.
: All participants in the EndAECOPD study were willing to attend the study and provided written informed consent.
: The authors declare that they have no competing interests.
